Centurion Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Centurion Wealth Management's PFE Position: Q3 2026 in Review
Centurion Wealth Management reduced its Pfizer (PFE) stake by 11% in Q3 2026, selling an estimated $29.8K and leaving 8,761 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #243.
Centurion Wealth Management first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $695K in Q4 2022. 642 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Centurion Wealth Management held 8,761 shares of Pfizer worth $250K as of Q3 2026.
- Centurion Wealth Management sold 1,119 Pfizer shares in Q3 2026, an estimated $29.8K.
- Pfizer made up 0.06% of Centurion Wealth Management's portfolio in Q3 2026, its #243 holding.
- Centurion Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- Centurion Wealth Management's Pfizer position peaked at $695K in Q4 2022.
- 642 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.